Anthem Biosciences Limited (BOM:544449)

India · Delayed Price · Currency is INR

808.75

+25.25 (3.22%)

At close: Jul 31, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Contract Research Development & Manufacturing Services (CRDMO)	17.73B	15.06B	8.98B	8.08B	9.47B
Speciality Ingredients	3.52B	3.38B	3.36B	2.49B	2.84B
R & D Services	-	-	1.86B	-	-
Total	21.24B	18.45B	14.19B	10.57B	12.31B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
North America (USA)	5.80B	4.99B	4.29B	5.00B	5.18B
Europe	11.45B	9.97B	6.13B	3.06B	4.60B
India	3.16B	3.06B	3.10B	2.13B	2.32B
Rest of Asia & Others	837.75M	430.20M	676.71M	374.95M	222.01M
Total	21.24B	18.45B	14.19B	10.57B	12.31B